Ultralife Corporation
ULBI
$7.79
$0.141.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -193.44% | -80.83% | -68.14% | -49.19% | -11.92% |
| Total Depreciation and Amortization | 32.28% | 36.18% | 25.63% | 16.27% | 6.29% |
| Total Amortization of Deferred Charges | 191.21% | 310.00% | 200.00% | 118.75% | 42.19% |
| Total Other Non-Cash Items | 380.68% | -43.01% | -36.39% | -32.60% | 19.68% |
| Change in Net Operating Assets | -84.51% | 288.35% | 220.26% | 158.09% | 135.21% |
| Cash from Operations | -33.94% | -21.69% | 64.58% | 525.12% | 762.42% |
| Capital Expenditure | -100.41% | -54.27% | -40.69% | -1.15% | 24.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.25% | -2,114.24% | -2,155.26% | -1,979.81% | -1,857.45% |
| Total Debt Issued | -- | 5,400.00% | 1,764.41% | 1,011.11% | 658.62% |
| Total Debt Repaid | 81.55% | 37.03% | 1.51% | -764.47% | -758.23% |
| Issuance of Common Stock | -95.10% | -93.68% | -96.03% | -32.02% | 60.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.28% | -1,882.35% | -- | -- | -- |
| Cash from Financing | -115.66% | 358.61% | 497.97% | 648.08% | 443.90% |
| Foreign Exchange rate Adjustments | 44.12% | -42.27% | 214.89% | 114.37% | 111.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.75% | 198.38% | 366.85% | -130.71% | -175.01% |